Grifols to Float U.S. Biopharma Unit in U.S. IPO to Strengthen Balance Sheet
Grifols’ board has approved an IPO of the company’s U.S. biopharma unit with the stated goal of raising cash to reduce debt and support growth. The Barcelona-based group will list a minority stake in the U.S. while keeping operational control and majority ownership. The unit runs nearly 300 donation centers in 40 states and employs over 14,000 peop…